Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Fleischmann

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Urology|May 1, 1991
Interleukin-2 immunotherapy followed by resection of residual renal cell carcinomaJ D Fleischmann, B Kim
The Journal of Urology|September 1, 1985
Endocrine therapy for bladder outlet obstruction from carcinoma of the prostateJ D Fleischmann, W J Catalona
Urology|August 1, 1990
Synchronous, primary bilateral lymphoma of testesG M Kirsh, J D Fleischmann, A H Toor
The Journal of Urology|February 1, 1993
Fibronectin expression on surgical specimens correlated with the response to intravesical bacillus Calmette-Guerin therapyJ D Fleischmann, M C Park, M O Hassan
The Journal of Urology|November 1, 1991
Clinical and immunological response to nifedipine for the treatment of interstitial cystitisJ D Fleischmann, H N Huntley, W B Shingleton, et al.
Immunological Investigations|June 1, 1989
Measurement of serum interleukin-2 activityJ D Fleischmann, D B Wentworth, K M Thomas, et al.
Immunological Investigations|July 1, 1989
Urinary interleukin-2 inhibition in patients with cystitisJ D Fleischmann, D B Wentworth, K M Thomas, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1991
Fibrinolysis, thrombocytopenia, and coagulation abnormalities complicating high-dose interleukin-2 immunotherapyJ D Fleischmann, W B Shingleton, C Gallagher, et al.
Biochemical and Biophysical Research Communications|April 29, 1988
Interleukin-2 self-associationJ D Fleischmann, D Wentworth, F Valencic, et al.
Cancer|October 1, 1989
Urinary interleukins in patients receiving intravesical Bacillus Calmette-Guerin therapy for superficial bladder cancerJ D Fleischmann, Z Toossi, J J Ellner, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Urology|May 1, 1991
Interleukin-2 immunotherapy followed by resection of residual renal cell carcinomaJ D Fleischmann, B Kim
The Journal of Urology|September 1, 1985
Endocrine therapy for bladder outlet obstruction from carcinoma of the prostateJ D Fleischmann, W J Catalona
Urology|August 1, 1990
Synchronous, primary bilateral lymphoma of testesG M Kirsh, J D Fleischmann, A H Toor
The Journal of Urology|February 1, 1993
Fibronectin expression on surgical specimens correlated with the response to intravesical bacillus Calmette-Guerin therapyJ D Fleischmann, M C Park, M O Hassan
The Journal of Urology|November 1, 1991
Clinical and immunological response to nifedipine for the treatment of interstitial cystitisJ D Fleischmann, H N Huntley, W B Shingleton, et al.
Immunological Investigations|June 1, 1989
Measurement of serum interleukin-2 activityJ D Fleischmann, D B Wentworth, K M Thomas, et al.
Immunological Investigations|July 1, 1989
Urinary interleukin-2 inhibition in patients with cystitisJ D Fleischmann, D B Wentworth, K M Thomas, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1991
Fibrinolysis, thrombocytopenia, and coagulation abnormalities complicating high-dose interleukin-2 immunotherapyJ D Fleischmann, W B Shingleton, C Gallagher, et al.
Biochemical and Biophysical Research Communications|April 29, 1988
Interleukin-2 self-associationJ D Fleischmann, D Wentworth, F Valencic, et al.
Cancer|October 1, 1989
Urinary interleukins in patients receiving intravesical Bacillus Calmette-Guerin therapy for superficial bladder cancerJ D Fleischmann, Z Toossi, J J Ellner, et al.
Pageof 2